Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical (LFCR) Total Debt: 2010-2025

Historic Total Debt for Lifecore Biomedical (LFCR) over the last 16 years, with May 2025 value amounting to $121.2 million.

  • Lifecore Biomedical's Total Debt rose 19.30% to $121.2 million in Q2 2025 from the same period last year, while for May 2025 it was $121.2 million, marking a year-over-year increase of 19.30%. This contributed to the annual value of $121.2 million for FY2025, which is 19.30% up from last year.
  • Per Lifecore Biomedical's latest filing, its Total Debt stood at $121.2 million for FY2025, which was up 19.30% from $101.6 million recorded in FY2024.
  • In the past 5 years, Lifecore Biomedical's Total Debt registered a high of $193.9 million during FY2021, and its lowest value of $84.8 million during FY2023.
  • For the 3-year period, Lifecore Biomedical's Total Debt averaged around $102.5 million, with its median value being $101.6 million (2024).
  • Its Total Debt has fluctuated over the past 5 years, first plummeted by 49.37% in 2022, then climbed by 19.75% in 2024.
  • Yearly analysis of 5 years shows Lifecore Biomedical's Total Debt stood at $193.9 million in 2021, then crashed by 49.37% to $98.2 million in 2022, then declined by 13.59% to $84.8 million in 2023, then grew by 19.75% to $101.6 million in 2024, then climbed by 19.30% to $121.2 million in 2025.